Medtronic (MDT) Change in Accured Expenses (2014 - 2026)

Medtronic has reported Change in Accured Expenses for 13 years, with the latest figure at $123.0 million in Q2 2026.

• Quarterly Change in Accured Expenses fell 66.39% year-over-year to $123.0 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $46.0 million (down 77.99% YoY) and the FY2026 annual result came in at $46.0 million, down 77.99% from the prior year.
• Change in Accured Expenses slipped to $123.0 million in Q2 2026 per MDT's latest filing, from $703.0 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $703.0 million in Q1 2026 and troughed at -$673.0 million in Q3 2023.
• A 5-year average of $111.2 million and a median of $155.0 million in 2022 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2022 and 2023: Change in Accured Expenses soared 10250.0% in 2022, then plunged 357.82% in 2023.
• Over 5 years, Change in Accured Expenses stood at $133.0 million in 2022, then slumped by 119.55% to -$26.0 million in 2023, then plunged by 296.15% to -$103.0 million in 2024, then sank by 76.7% to -$182.0 million in 2025, then soared by 167.58% to $123.0 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered $123.0 million, $703.0 million, and -$182.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.